Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462811 | 12646281 | 1 | I | 20160801 | 20160808 | 20160812 | 20160812 | EXP | BR-ROCHE-1811027 | ROCHE | 91.38 | YR | Y | 51.65000 | KG | 20160812 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462811 | 12646281 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | Y | H0189B02 | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
| 126462811 | 12646281 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Y | H0189B02 | 103705 | ||||||||||
| 126462811 | 12646281 | 3 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | Y | 5QL0025 | 0 | 10 | MG/M**2 | INFUSION | ||||||
| 126462811 | 12646281 | 4 | SS | Doxorubicin | DOXORUBICIN | 1 | Y | 5QL0025 | 0 | ||||||||||
| 126462811 | 12646281 | 5 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | Y | 18060 | 0 | 50 | MG/M**2 | INFUSION | ||||||
| 126462811 | 12646281 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Y | 18060 | 0 | ||||||||||
| 126462811 | 12646281 | 7 | SS | vincristine | VINCRISTINE | 1 | Unknown | Y | 15K0179 | 0 | .4 | MG/M**2 | INFUSION | ||||||
| 126462811 | 12646281 | 8 | SS | vincristine | VINCRISTINE | 1 | Y | 15K0179 | 0 | ||||||||||
| 126462811 | 12646281 | 9 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | Y | 5L091A | 0 | 750 | MG/M**2 | |||||||
| 126462811 | 12646281 | 10 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Y | 5L091A | 0 | ||||||||||
| 126462811 | 12646281 | 11 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 60 | MG/M**2 | |||||||||
| 126462811 | 12646281 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126462811 | 12646281 | 1 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 2 | Diffuse large B-cell lymphoma |
| 126462811 | 12646281 | 3 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 4 | Diffuse large B-cell lymphoma |
| 126462811 | 12646281 | 5 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 6 | Diffuse large B-cell lymphoma |
| 126462811 | 12646281 | 7 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 8 | Diffuse large B-cell lymphoma |
| 126462811 | 12646281 | 9 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 10 | Diffuse large B-cell lymphoma |
| 126462811 | 12646281 | 11 | Non-Hodgkin's lymphoma |
| 126462811 | 12646281 | 12 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126462811 | 12646281 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126462811 | 12646281 | Mucosal inflammation | |
| 126462811 | 12646281 | Neutropenia | |
| 126462811 | 12646281 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |